can semaglutide reduce inflammation Semaglutide-Mediated Remodeling of Adipose Tissue in Type 2 Diabetes: Molecular Mechanisms Beyond Glycemic Control A 2025 Lancet analysis of

By month three, weight loss may become more visible

Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks

Skip if you lack laboratory training or sterile handling capability

Tirzepatide is one of many increasingly popular weight loss injectable medications that help individuals lose considerable quantities of weight

Both are GLP-1 agonists, but are synthesized differently

M.KratzM.DammanC